V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220020453 | 220006196 | 1.63 | 58.3 | Curative (C) | 2016-07-09 | 2016-07-11 | AML 19 TRIAL | N | N | 220023499 | AML19 TRIAL |
| 220020454 | 220019485 | 1.72 | 72 | Curative (C) | 2017-12-30 | 2018-02-07 | AML 19 TRIAL | Y | N | 220023564 | AML19 TRIAL |
| 220020456 | 220006215 | 1.68 | 68.3 | Curative (C) | 2015-12-23 | 2016-03-17 | AML 19 TRIAL | Y | N | 220023606 | AML19 TRIAL |
| 220020457 | 220006222 | 1.72 | 67.8 | Curative (C) | 2017-05-25 | 2017-08-07 | AML 19 TRIAL | N | N | 220023625 | AML19 TRIAL |
| 220020458 | 220006226 | null | 95.7 | Palliative (P) | 2015-05-08 | 2015-08-21 | Trial Unspecified | N | N | 220023640 | TRIAL |
| 220020459 | 220006229 | 1.81 | 0 | Disease modification (D) | 2014-04-29 | 2014-04-29 | Trial Unspecified | 02 | N | 220023646 | TRIAL |
| 220020460 | 220006233 | 1.72 | 79.4 | Curative (C) | 2016-07-11 | 2016-07-11 | Trial Unspecified | Y | N | 220023647 | TRIAL |
| 220020461 | 220006238 | 1.62 | null | Curative (C) | 2014-03-17 | 2014-03-17 | AML 19 TRIAL | N | N | 220023671 | AML19 TRIAL |
| 220020462 | 220006241 | 1.77 | 59.6 | Curative (C) | null | 2016-12-29 | AML 19 TRIAL | N | N | 220023676 | AML19 TRIAL |
| 220020463 | 220006243 | 1.78 | 0 | Curative (C) | 2014-02-21 | 2014-04-16 | Trial Unspecified | Y | null | 220023681 | TRIAL |
| 220020464 | 220006247 | 1.66 | 56 | Adjuvant (A) | 2016-11-21 | 2016-11-21 | AML 19 TRIAL | N | N | 220023701 | AML19 TRIAL |
| 220020465 | 220006257 | 1.84 | 100 | null | 2013-08-29 | 2013-08-29 | AML 19 TRIAL | 01 | N | 220023737 | AML19 TRIAL |
| 220020466 | 220019492 | 1.63 | 49.5 | Curative (C) | 2014-07-18 | 2014-08-26 | Trial Unspecified | Y | N | 220023739 | TRIAL |
| 220020468 | 220006263 | 1.76 | 106 | Curative (C) | 2015-07-20 | 2015-07-24 | AML 19 TRIAL | N | N | 220023759 | AML19 TRIAL |
| 220020469 | 220006268 | null | 57.6 | Disease modification (D) | 2017-03-29 | 2017-03-29 | Trial Unspecified | 02 | N | 220023778 | TRIAL |
| 220020470 | 220006271 | null | 66.6 | Curative (C) | 2013-09-14 | 2013-09-14 | AML 19 TRIAL | Y | null | 220023793 | AML19 TRIAL |
| 220020471 | 220006277 | 1.59 | 69.2 | Curative (C) | 2014-10-29 | 2015-01-01 | Trial Unspecified | Y | N | 220023811 | TRIAL |
| 220020472 | 220013387 | 0 | 88.9 | Curative (C) | 2017-05-03 | 2017-09-28 | AML 19 TRIAL | Y | N | 220023821 | AML19 TRIAL |
| 220020474 | 220006288 | 1.76 | 66 | Disease modification (D) | 2014-12-10 | 2014-12-12 | Hydroxycarbamide | N | N | 220023833 | HYDROXYCARBAMIDE |
| 220020475 | 220013396 | 1.65 | 0 | Palliative (P) | 2018-10-09 | 2018-10-09 | Hydroxycarbamide | 99 | N | 220023866 | HYDROXYCARBAMIDE |
| 220020476 | 220006300 | 0 | null | Curative (C) | 2017-11-05 | 2017-11-09 | Hydroxycarbamide | N | N | 220023873 | HYDROXYCARBAMIDE |
| 220020477 | 220006301 | null | 8.8 | Curative (C) | null | 2017-07-19 | FLUDARABINE + THIOTEPA + TREOSULFAN | N | N | 220023877 | NOT MATCHED |
| 220020478 | 220006308 | null | null | Palliative (P) | null | 2014-01-06 | CYTARABINE | 2 | N | 220023897 | CYTARABINE |
| 220020479 | 220017327 | 1.51 | 65.1 | Curative (C) | 2017-01-25 | 2017-01-25 | AML MyeChild 01 FLA-Idarubicin | N | N | 220023938 | NOT MATCHED |
| 220020480 | 220006322 | 0 | 81 | Disease modification (D) | 2017-08-15 | 2017-08-22 | CYTARABINE | N | N | 220023967 | CYTARABINE |
| 220020481 | 220006327 | 1.51 | 70.3 | Palliative (P) | 2019-08-12 | 2019-08-13 | Cytarabine Low Dose | N | N | 220023982 | CYTARABINE |
| 220020482 | 220013421 | 1.76 | null | Curative (C) | 2016-08-22 | 2016-09-30 | null | 2 | N | 220024000 | NOT MATCHED |
| 220020483 | 220006331 | null | 74.5 | Disease modification (D) | 2018-03-31 | 2018-04-05 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220024003 | CYTARABINE |
| 220020484 | 220013424 | 1.83 | null | Disease modification (D) | 2018-04-26 | 2018-04-26 | Hydroxycarbamide | 2 | N | 220024004 | HYDROXYCARBAMIDE |
| 220020485 | 220013426 | 1.66 | null | Disease modification (D) | 2017-11-27 | 2017-11-27 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220024041 | CYTARABINE |
| 220020486 | 220019507 | 1.65 | 41 | Disease modification (D) | null | 2015-02-22 | null | 2 | N | 220024091 | NOT MATCHED |
| 220020487 | 220006339 | 0 | 33.4 | Curative (C) | 2016-09-16 | 2016-10-13 | AML Relapsed FLA - DaunoXome | 2 | N | 220024098 | NOT MATCHED |
| 220020488 | 220006343 | 1.31 | 76 | Curative (C) | 2013-10-12 | 2014-01-08 | Cytarabine Low Dose | N | N | 220024100 | CYTARABINE |
| 220020490 | 220017348 | 1.74 | 87.1 | Curative (C) | 2013-01-03 | 2017-09-25 | Cytarabine Intrathecal (any age) | null | null | 220024163 | CYTARABINE |
| 220020491 | 220006356 | 1.87 | 29.4 | Palliative (P) | 2013-12-10 | 2014-03-11 | null | 02 | N | 220024182 | NOT MATCHED |
| 220020492 | 220006364 | null | 97 | Palliative (P) | 2017-07-02 | 2017-07-03 | CYTARABINE | 02 | N | 220024207 | CYTARABINE |
| 220020493 | 220006367 | 1.8 | 84.4 | Disease modification (D) | 2015-05-14 | 2015-05-14 | CYTARABINE | N | N | 220024225 | CYTARABINE |
| 220020494 | 220006369 | 1.62 | 66 | Palliative (P) | null | 2014-07-28 | Hydroxycarbamide | N | N | 220024229 | HYDROXYCARBAMIDE |
| 220020495 | 220006377 | 0 | 108 | null | 2015-09-05 | 2016-06-17 | Hydroxycarbamide | 02 | N | 220024262 | HYDROXYCARBAMIDE |
| 220020496 | 220006385 | null | 104 | Palliative (P) | 2014-10-09 | 2014-10-23 | Cytarabine Low Dose | null | N | 220024302 | CYTARABINE |
| 220020497 | 220006387 | null | null | Disease modification (D) | 2015-06-24 | 2015-06-25 | Hydroxycarbamide | null | N | 220024304 | HYDROXYCARBAMIDE |
| 220020498 | 220006392 | 0 | null | Disease modification (D) | 2016-10-15 | 2017-04-01 | Hydroxycarbamide | N | N | 220024319 | HYDROXYCARBAMIDE |
| 220020499 | 220006398 | null | 73.2 | Disease modification (D) | 2016-03-16 | 2016-03-16 | Hydroxycarbamide | N | N | 220024325 | HYDROXYCARBAMIDE |
| 220020500 | 220021445 | 1.48 | 7.6 | Curative (C) | 2015-08-09 | 2015-11-21 | AML MyeChild 01 A Mitozantrone/Cytarabine | N | N | 220024326 | NOT MATCHED |
| 220020501 | 220006406 | null | 5.4 | Curative (C) | 2015-06-04 | 2015-07-17 | CYTARABINE + ETOPOSIDE + MITOXANTRONE | 2 | N | 220024353 | NOT MATCHED |
| 220020502 | 220017362 | null | 88.6 | Curative (C) | 2015-06-10 | 2015-06-10 | Cytarabine Low Dose | Y | N | 220024357 | CYTARABINE |
| 220020503 | 220006413 | 0 | null | Curative (C) | 2018-01-10 | 2018-02-14 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220024371 | CYTARABINE |
| 220020505 | 220006421 | null | 9.8 | Curative (C) | 2018-01-15 | 2018-01-15 | null | null | null | 220024410 | NOT MATCHED |
| 220020506 | 220013486 | 1.85 | null | Curative (C) | 2014-03-17 | 2014-03-17 | Hydroxycarbamide | N | null | 220024416 | HYDROXYCARBAMIDE |
| 220020507 | 220006426 | 1.54 | null | Curative (C) | 2018-09-24 | 2018-12-11 | CYTARABINE | N | N | 220024421 | CYTARABINE |